Apple, Masimo Smartwatch Trade Secrets Lawsuit Ends in Mistrial After Jurors Fail to Reach Verdict

A Masimo spokesperson said in a statement that the company was "disappointed that the jury was unable to reach a verdict."

By Reuters | Updated: 2 May 2023 10:39 IST

Apple, Masimo Smartwatch Trade Secrets Lawsuit Ends in Mistrial After Jurors Fail to Reach Verdict

Photo Credit: Apple

Apple sued Masimo in Delaware last year, accusing it of patent infringement

Highlights

Masimo has also sued Apple at the US ITC to violate its patent rights
Apple is facing another potential Apple Watch import ban
Masimo asked for more than $1.8 billion (roughly Rs. 147.15 crore)

A US judge in California on Monday declared a mistrial in Masimo's smartwatch trade secret lawsuit against Apple after jurors failed to reach a unanimous verdict in the potential billion-dollar case.

A Masimo spokesperson said in a statement that the company was "disappointed that the jury was unable to reach a verdict" but intends to retry the case.

The jury in federal court in Santa Ana had been asked to determine whether Cupertino, California-based Apple misused confidential information from Masimo related to the use of light to measure biomarkers including heart rates and blood oxygen levels.

[Sponsored] Samsung Galaxy S24: The Ultimate Camera Phone With Smarter On-Device AI

The jury began deliberating on April 26 after a trial lasting about three weeks before US District Judge James Selna.

Apple said in a statement that it "deeply respects intellectual property and innovation and does not take or use confidential information from other companies," and will ask the court to dismiss the remaining claims in the case.

Irvine, California-based Masimo and its spinoff Cercacor Laboratories Inc sued Apple in 2020, accusing it of stealing trade secrets and using them to create and sell several Apple Watch models.

Apple's watchOS 10 Update to Introduce Widget-Focussed Interface: Gurman

The lawsuit claimed Masimo representatives met with Apple in 2013 about integrating its inventions into Apple products and that Apple subsequently hired away two executives - one from Masimo and one from Cercacor - and used their knowledge to copy the technology.

Masimo asked for more than $1.8 billion (roughly Rs. 147.17 crore) in damages, reduced from its initial request for $3.1 billion (roughly Rs. 253.45 crore) after the judge dismissed some of its trade-secret claims during trial.

Apple in a court filing called Masimo's lawsuit a "maneuver to clear a path" for its own smartwatch. Apple sued Masimo in Delaware last year, accusing it of patent infringement.

Meta Said to Be Targeting $7 Billion in Its Second Blue-Chip Bond Sale

Smartwatches, mobile devices worn on the wrist with an array of capabilities, are a lucrative market, with global sales worth tens of billions of dollars.

Masimo has also sued Apple at the US International Trade Commission over Apple Watch imports that it said violated its patent rights. An ITC judge preliminarily ruled in favor of Masimo in January, which could lead to an import ban on infringing Apple Watches if the full commission affirms the decision.

Apple is facing another potential Apple Watch import ban in a separate patent fight with Mountain View, California-based medical device maker AliveCor over heart-monitoring technology.

Apple is opening its first stores in India, one in Mumbai and the other in Delhi. What does this mean for Apple customers in India? We discuss this and more on Orbital, the Gadgets 360 podcast. Orbital is available on Spotify, Gaana, JioSaavn, Google Podcasts, Apple Podcasts, Amazon Music and wherever you get your podcasts.

Affiliate links may be automatically generated - see our ethics statement for details.

Comments

For the latest tech news and reviews, follow Gadgets 360 on X, Facebook, WhatsApp, Threads and Google News. For the latest videos on gadgets and tech, subscribe to our YouTube channel. If you want to know everything about top influencers, follow our in-house Who'sThat360 on Instagram and YouTube.